Medtronic (NYSE:MDT) is all-in on the surgical robotics game now that’s inked a deal to buy Mazor Robotics (NSDQ:MZOR) for more than $1.6 billion in cash.
The world’s largest medical device maker has held a position in Mazor, which makes the Mazor X guidance system and the Renaissance robot-assisted spine surgery platform, since May 2016. In September they closed the third, $40 million tranche of the investment, giving Medtronic a 10.6% stake it paid $72 million for.
